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Abstract
In 1967, the first cardiac transplantation was performed in South Africa by Christiaan
Barnard, becoming one of the most pioneering events of the human history, comparable to
the first step on the moon, 2 years later. Even if Barnard became extremely famous because
of this outstanding operation, behind this event there were years and years of studies,
experimentations and hard work done by others, in particular by Lower and Shumway.
The initial technique, still called ‘standard technique’ is the biatrial one. In the late 1980s,
alternatives like the ‘bicaval technique’ were developed in order to get a more anatomical
result. In the present chapter, we will throw the reader into the early years of the cardiac
transplantation era, describing all the efforts made by the “fathers” of the cardiac surgery
in order to standardize techniques inherited by the modern surgeons. Afterwards, we will
present a review of the literature to answer the question if the biatrial technique should
still be called “standard technique”.
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1. Historic background of cardiac transplantation surgical techniques
On December 3, 1967 in Cape Town, Christiaan Barnard performed the first human heart
transplant. This was one of the most significant accomplishments in history, allowing to save
the life of several patients with end-stage heart disease in the last 50 years. This remarkable
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surgical innovation was the result of constant work, diligent research, creativity and innovative
perception. During the early 1900s, Alexis Carrel, the father of vascular and transplant surgery
who was awarded the Nobel Prize in Physiology or Medicine in 1912, and Charles Guthrie,
professor of Physiology and Pharmacology at Washington University, performed the first
heterotopic heart transplant [1]. Subsequently, other American surgeons, including Mann [2]
at Mayo Clinic in 1933 and Marcus [3] at Chicago Medical School two decades later, pursued
the experimentation and proposed new techniques for heterotopic heart transplantation. At
the same time, on the other side of the world, Vladimir Demikhov at M.V. Lomonosov Moscow
State University gave a considerable contribution to this experimental specialty, performing
the first combined heart-lung transplant and also the first orthotopic transplant in dogs with-
out the use of hypothermia and pump-oxygenator support. His technique consisted of end-to-
side anastomoses between the corresponding thoracic aortae, superior venae cavae, inferior
venae cavae, and pulmonary arteries. The donor’s inferior pulmonary veins were joined
together and connected to the recipient’s left atrial appendage. Then, the portion of recipient’s
heart excluded from circulation was ligated and excised [4]. Unfortunately, Demikhov’s
research remained unknown for a long time and it was published in English only in 1962.
The introduction of hypothermia and cardiopulmonary bypass in the early 1950s had a deci-
sive impact on heart transplantation research.
In the late 1950s, Shumway and Lower at Stanford University achieved brilliant results
experimenting on dogs [5]. They used a simple and effective surgical technique, called
“Shumway” or biatrial technique (BA), where the anterior part of donor’s left and right atria
was incised and anastomosed to the posterior wall of the recipient’s atria. This became the
standard heart transplant surgical technique until the 1990s. These two pioneers also intro-
duced two innovative methods that allowed to prolong survival times: the use of isotonic
saline solution at 4C to preserve the donor’s heart and the use of cardiopulmonary bypass to
support the transplanted heart [6].
Based on these promising premises, Shumway begun to think about human heart transplant.
This research recalled the attention of the international scientific community, in particular of
Christiaan Barnard, a young South African surgeon with a good reputation in open heart
surgery who developed almost an obsession for heart transplantation. In August 1966, he
spent 4 months in Lower’s laboratory learning the principles of Shumway’s research.
At his return to South Africa, on December 3, 1967, he performed the first heart transplant [7].
The donor was Denise Darvall, a 25-year-old woman who had a severe brain injury and was
certified brain dead by the neurosurgeons. The recipient was Luois Washkansky, a 53-year-old
man with severe heart failure; he died 17 days later due to pneumonia [8].
On December 6, 1967, Adrian Kantrowitz, another pioneer in this field, performed the first
pediatric heart transplantation at Maimonides Hospital of New York. The donor was an
anencephalic baby and the recipient was an 18-day-old child with Ebstein anomaly. Unfortu-
nately, the young patient died after 6 hours [9].
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One month later, on January 6, 1968, Shumway and his team performed the first human heart
transplant in the United States. The patient died of gastrointestinal bleeding on the 15th
postoperative day.
During the next year, 102 heart transplants were performed around the world, with only 40%
survival at 1 year [7]. These poor results were the reason why the most important cardiovas-
cular surgery centers abandoned the procedure.
After these first attempts, heart surgeons realized that specific suppression of the recipient’s
immune system was required for long-term graft survival. After the introduction of percuta-
neous transvenous endomyocardial biopsy in 1973, that improved the diagnosis of acute and
chronic rejection, and the discovery of cyclosporine A in 1976, a powerful immunosuppressor,
better results in terms of survival were achieved, therefore a greater number of procedures was
performed [6].
While the “Shumway technique” remained the standard for more than 20 years worldwide, in
the early 1990s, some surgeons proposed new effective surgical techniques trying to improve
hemodynamic results and late survival [10]. Despite the technical evolution, in the last 50 years,
despite the improvement in pharmacological treatment of end-stage heart failure, cardiac
transplantation has remained the only treatment (along with left ventricle assistance devices
(LVAD) implantation as destination therapy) capable of improving the long-term survival
[11, 12]. The standard BA technique, based on the description of Cass and Brock [13] and
Lower and Shumway [5] for orthotopic heart transplantation (OHT), was adopted worldwide
for many years due to its simplicity and reproducibility. This technique requires, to some
extent, the excision of the posterior part of the donor’s left atrium and the incision of the right
atrium from the inferior vena cava toward the right atrial appendage to avoid injuries to the
sino-atrial node. The atrial anastomoses can be performed easily, reducing from 8 possible
single-vessel anastomoses for complete transplantation to 4 (Figure 1).
However, several studies have demonstrated that the drawback of this technique consists in
enlarged, figure-of-eight configured right and left atria without a physiological geometry
between the donor and the recipient’s atria [14]. This non physiological geometry can lead to
(i) higher incidence of mitral and tricuspid valve incompetence, (ii) rhythm disturbances [14]
and (iii) tendency of thrombus formation and septal aneurysm [15]. Because of these problems,
some authors, as Sir Magdi Yacoub, Banner and Dreyfus some time later [16–18] proposed a
more anatomical surgical technique with complete excision of the recipient’s atria and direct
anastomoses to the left pulmonary veins, right pulmonary veins, inferior venae cavae (IVC),
and superior venae cavae (SVC). No technical complications occurred, but the benefit of this
procedure on clinical outcome had to be demonstrated, at least in the 1990s.
Sievers and co-workers [19] in 1991, and the Wythenshawe group [20] in 1993, introduced into
clinical practice the bicaval transplantation technique (BC), characterized by two arterial, one left
atrial, and two caval anastomoses, leaving the right atrium intact and leaving only a small
posterior part of recipient’s left atrial tissue between the pulmonary veins (Figure 2). Potential
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Figure 1. A schema of the Biatrial technique for orthotopic cardiac transplantation is shown. In the left (A), after
cardiectomy, the double atrial cuff is distinguishable, with the interatrial septum with the foramen. In the right, (B) the
right atrial cuff suture is represented.
Heart Transplantation112
Figure 2. The schema of the Bicaval technique has been designed. In the left side (A), both cavas and the left atrial cuff are
prepared after cardiectomy, while in the right side (B) the final result with both superior and inferior vena cava sutures.
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shortcomings of the BC technique include the marginally prolonged ischemic transplantation
time, which is likely of no clinical relevance, as well as some sort of stenosis at the level of the
venous anastomoses. Both problems, however, can be neutralized by refined surgical techniques.
2. Biatrial vs. bicaval technique: Best evidences
During the 1990s, many single center reports, with variable potency and sample size have been
published, comparing both techniques from different points of view and outcomes, like post-
operative mortality, length of operation in terms of ischemic organ time, length of hospital stay,
need for permanent pace maker, echocardiographic findings, exercise capacity and long-term
survival.
Remarkable is the paper of Sun et al. [21] with a total of 615 enrolled patients. Among them,
322 were transplanted using the BC technique and 293 using the BA technique. There was no
statistically significant difference in terms of early mortality (within 30 post-operative days)
between the two groups (3.4% in the BC group vs. 4.8% in the BA group, p 0.5). The average
follow-up period was 4.0  3.0 years (ranging from 1 to 11 years). There was no significant
difference between groups (3.8  3.5 years in Group 1, 3.8  3.8 years in Group 2). Survival
rates at 1, 5 and 10 years were 93, 89 and 87% in the BC group and 89, 82 and 80% in the BA
group, respectively. Long-term survival differed significantly between the two groups and the
cumulative proportion of survival was significantly higher in the BC group than in the BA
group (p 0.05). In the univariate regression analysis, several echocardiographic parameters,
such as left atrial diameter, mitral regurgitation, tricuspid regurgitation, left ventricular ejec-
tion fraction, right ventricular ejection fraction and surgical techniques, were predictors of
long-term survival. Both mitral and tricuspid regurgitation were weakly associated with mor-
tality. There were significant correlations between left and right ventricular ejection fraction
and surgical techniques with mortality outcome. Using a multivariate model of analysis, left
and right ventricular ejection fraction remained significant risk factors for mortality. When
adjusted for left and right ventricular ejection fraction, the surgical techniques (BC vs. BA)
significantly influenced mortality outcome in the multivariate analysis. Any significant differ-
ence in the incidence of mitral regurgitation between BC and BA transplant patients was
demonstrated. However, tricuspid valve regurgitation was much more common in the BA
group than in the BC group. They concluded that the BC technique helps to decrease atrial
size and tricuspid regurgitation, and better preserves right and left heart function, resulting in
improved long-term survival after heart transplantation compared with the BA technique.
Other authors have demonstrated that the BC technique leads to an increased parasympathetic
reinnervation compared with the standard technique, which might be of clinical relevance
because an increase in blood pressure control, by larger reflex changes in heart rate, might
improve adaptation to various stimuli and to physical exercise [22].
However the best way to reach some conclusion is by analyzing papers with the strongest
evidences. Relevant among these, two multicenter studies from the UNOS database and other
two meta-analysis (see Table 1).
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Davies et al. [23] recently reported from the UNOS data base an analysis of 20,999 transplan-
tations performed on adult patients with no congenital heart disease between 1997 and 2007,
including the type of anastomosis performed. Patients were stratified accordingly to the atrial
anastomosis technique: standard BA (atrial group, n. 11,919 [59.3%]), BC (caval group, n. 7661
[38.1%]), or total orthotopic (total group, n. 519 [2.6%]). First of all, until 2003, the BA technique
Author/
year
Institution Study Type Patients TVR PM
Insertion
Mortality Survival
Wartig
et al.
2014 [30]
Sahlgrenska
University
Hospital,
Gothenburg,
Sweden
Retrospective
Cohort Study
BA: 221
BC: 226
BA:
Mild: 103 (37%)
Moderate/
Severe: 63
(61%)*
BC:
Mild: 169 (61%)
Moderate/
Severe: 39
(38%)
NA 48 (9.9%) 1 year: 84%*
5 years: 73%
10 years: 58%
15 years: 43%
20 years: 27%
Davies
et al.
2010 [23]
Columbia
University,
New York,
USA
Retrospective
Review
UNOS
database
BA: 11.919 (59.3%)
BC: 7.661 (38.1%)
Total: 519 (2.6%)
NA BA: 576
(5.1%)
BC: 146
(2.0%)
Total: 11
(1.9%)
BA: 8.9%
BC: 7.6%
Total: 9.5%
BA:
1 year: 85.6%*
5 years: 72.2%*
10 years:
51.1%*
BC:
1 year: 87.1%
5 years: 73.5%
10 years:
57.4%
Weiss
et al.
2008 [24]
Johns
Hopkins
Medical
Institution,
Baltimore,
USA
Retrospective
Review
UNOS
database
BA: 6.724
BC: 5.207
NA BA: 343
(5.3%)
BC: 103
(2.0%)
BA:
30-days: 6.6%
1 year: 13.4%
BC:
30-days: 5.4%
1 year: 11.5%
BA:
30-days: 93%
1 year: 86%
3 years: 79%
5 years: 72%
BC:
30-days: 94%
1 year: 87%
3 years: 81%
5 years: 75%
Locali
et al.
2008 [28]
Universidade
Federal São
Paulo, Brazil
Meta-analysis BA: 914
BC: 872
BA: 310/685
(45.2%)
BC: 184/593
(31%)
NA BA: 102/547
(18.6%)
BC: 64/585
(10.9%)
NA
Schnoor
et al.
2007 [10]
Medical
University
Schleswig-
Holstein,
Luebeck,
Germany
Meta-analysis BA: 1.803
BC: 1.968
BA: 153/261
(58.6%)
BC: 61/211
(28.9%)
NA BA: 18/110
(16.4%)
BC: 9/118
(7.6%)
NA
BA: biatrial; BC: bicaval; NA: not analyzed; PM: pace-maker; TVR: tricuspid valve repair; *= p< .01.
Table 1. Overview and outcomes of Biatrial vs. Bicaval for orthotopic heart transplantation.
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was used more frequently than the BC one, while the number of total transplantation decreased.
In 2006, more than 34% of the cases of cardiac transplantation were performed with the “stan-
dard” or BA technique. The percentage of transplantations performed with the BC technique
was higher at higher-volume transplant centers.
Regarding the outcomes, the need for permanent pacemaker was increased in patients in the
atrial group (n. 576, 5.1%) requiring a PPM before discharge more often (odds ratio [vs. the
caval group], 2.6; 95% CI, 2.2–3.1) than the caval group (n. 146, 2.0%) or the total group (n. 11,
1.9%; odds ratio [vs. the caval group], 1.0, 95% CI, 0.6–1.7). Multivariate predictors of the need
for PPM implantation included BA anastomosis (odds ratio, 3.1; 95% CI, 2.5–3.9), donor age of
60–69 years (odds ratio, 2.9; 95% CI, 1.5–5.3), donor age of 50–59 years (odds ratio, 2.0; 95% CI,
1.6–2.5), donor age of 40–49 years (odds ratio, 1.3; 95% CI, 1.0–1.6), recipient inotropic support
at transplantation (odds ratio, 1.5; 95% CI, 1.2–1.7), donor history of hypertension (odds ratio,
1.2; 95% CI, 1.0–1.4), and transplantation year (odds ratio, 1.04; 95% CI 1.01–1.07 [per year]);
use of T4 before organ retrieval (odds ratio, 0.8; 95% CI, 0.6–0.9) was protective.
In terms of hospital length of stay, patients in the atrial group had longer posttransplantation
stay (21.1 days) than those in the caval group (19.3 days, P < 0.0001).
In univariate analysis atrial group patients had a higher incidence of postoperative death
(8.9%; odds ratio, 1.17; 95% CI, 1.05–1.30) than those in the caval group (7.6%; odds ratio,
0.83; 95% CI, 0.75–0.93); postoperative mortality in the total group (9.5%; odds ratio, 1.14; 95%
CI, 0.86–1.53) was not significantly different from the one seen in either of the other groups.
However, the logistic regression model predicting postoperative death did not include the type
of anastomosis.
Also in the long-term outcomes, the need for PPM implantation was significantly higher
among patients in the atrial group, (P < 0.0001): at 2 years, 8.6% required a pacemaker versus
only 5.4% in the BC group and 4.0% in the total group. Multivariate predictors of the interval
time between transplantation and PPM insertion included other factors, like recipient age
(odds ratio, 1.006; 95% CI, 1.001–1.012 [per year]), transfusions between listing and transplan-
tation (odds ratio, 1.2; 95% CI, 1.0–1.4), donor age of 50 to 59 years (odds ratio, 1.6; 95% CI,
1.3–2.0), donor’s age of 60 to 69 years (odds ratio, 2.2; 95% CI, 1.3–3.7), transplantation year
(odds ratio, 1.25; 95% CI, 1.21–1.28 [per year]), and BA anastomosis (odds ratio, 2.5; 95% CI,
2.2–2.9); ventricular assistance device at transplantation was protective in this model (odds
ratio, 0.7; 95% CI, 0.6–0.9). There was a small but significant difference in long-term survival
between the atrial and caval groups in univariate analysis (survival at 1 year, 85.6 vs. 87.1%; at
5 years, 72.2 vs. 73.5%; at 10 years, 51.1 vs. 57.4%; P < 0.0168). Multivariate Cox proportional
hazards regression analysis confirmed the decreased survival among patients in the atrial
group (hazard ratio, 1.11; 95% CI, 1.04–1.19). There was no difference in graft survival, renal
failure-free survival, and transplant coronary atherosclerosis–free survival, based on anasto-
motic technique.
Three years before the UNOS analysis from Davies et al. [23], Weiss et al. [24] conducted a
retrospective review of the UNOS database from January 1999 to December 2005. A total of
14,418 patients underwent first-time OHT during this period. After exclusion of patients aged
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less than 18 years (n. 1831) and more than 80 years (n. 2), orthotopic total transplants (n. 482),
heterotopic transplants (n. 4) and those without data on transplant technique (n. 139), the final
study population was 11,931. Of these, 5207 (43%) received the BC anastomotic technique,
with follow-up through September 2006. Almost 10,000 patient less than the population
analyzed by Davies et al. [23]. Weiss et al. concluded that there was no difference in survival
between BC and BA techniques when modeled with long-term follow-up and adjusted for
confounding variables. Although the mortality rates were higher for the BA group at 30 days
and 1, 3 and 5 years, this represents unadjusted mortality, which disappears in both the logistic
regression and proportional hazards model for all time-points. Comparing both studies, we
can conclude that probably the results obtained by Davies et al., due to the sample size and the
interval period, are complementary to those obtained in the previous Weiss’ UNOS analysis,
giving more conclusive information. Also the BC technique gives the advantage of decreasing
both the need of PPM and the post-operative mortality, but also influences positively the long
term survival.
Regarding two relevant meta-analysis, the first one, published by Schnoor et al. [10] in 2007,
provides evidences that the expected theoretic advantages of BC transplantation, in compari-
son with the standard technique, have come true in clinical practice. The meta-analysis
included 23 retrospective and 16 prospective studies. In prospective trials, a reduction in right
atrial pressure was found. The absolute difference in right atrial pressure is probably of no
clinical relevance at rest but it probably could be on exertion. It has been suggested that the
patients with BC heart transplant may have superior exercise performance in comparison with
BA heart transplant. An attempt to solve this dilemma has been done in 2011 by Czer et al.
[25]: he did not found any significant difference in the exercise capacity between patients with
BA versus BC techniques for orthotopic heart transplantation. Other factors such as cardiac
denervation and immunosuppressive drug effect, or physical deconditioning, may be more
important determinants of subnormal exercise capacity after heart transplantation. Neverthe-
less, the reduction in morbidity and postoperative complications and the simplicity in the BC
technique suggest that the BC heart transplantation offers advantages when compared to the
standard BA technique.
Another study by Aleksic et al. demonstrated that the BC technique improves resting hemo-
dynamics in patients with high preoperative pulmonary vascular resistance as highlighted by
higher cardiac output and index with lower right atrial pressures. Further studies by Aleksic
et al. showed that the BC technique improved hemodynamics during episodes of cellular
rejection (grade 1B-1R or greater) and during antibody-mediated rejection [26, 27].
Other conclusions from the Schnoor meta-analysis confirmed the outcomes of other single center
results, like a higher rate of sinus rhythm after transplantation in the BC group, as well as the
significantly reduced rate of tricuspid valve regurgitation, the prevention of contraction abnor-
malities by the acute atrial enlargement with the standard technique, and the asynchrony of
recipient and donor atrial innervation, improving hemodynamic effects after BC transplantation.
The enlargement and distension of the atria typical of the standard technique might not only
induce an impairment of the electrical impulse initiation and conduction, triggering arrhythmias,
but also promote atrial thrombus formation, most likely avoided using the BC technique.
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Another relevant meta-analysis is the one conducted by the Brazilian group from San Paolo.
Fagionato et al. [28] aimed at increasing the statistical power of the evidences supporting the
new techniques against the BA transplantation, thus adding significance to the results of
Schnoor et al. They demonstrated many advantages of the BC technique on the BA one: first
of all, the ischemia time in the BC group, even when longer, as found in some studies, is
compensated by a better cardiac performance with the new techniques, since adequate ven-
tricular filling is dependent on a satisfactory atrial function. Furthermore, the incidence of
atrial arrhythmias was lower in the group undergoing BC transplantation, like in Schnoor’s
study. This can be explained by the preservation of the sino-atrial node integrity. Modifications
in the atrial geometry predispose to atrial arrhythmias, as well as increased internal pressure,
since these events prolong the electrical conduction time. The severity of the newly developed
arrhythmias is known to be also related and proportional to the severity of the rejection.
Fagionato’s results show no differences between the transplantation techniques in terms of
rejection, concluding that the episodes of atrial arrhythmias are mainly due to greater defor-
mity and atrial pressure. In this context, the rejection episodes can also be related to the degree
of tricuspid valve regurgitation. In 2002, Aziz et al. [29] showed that individuals with moder-
ate or severe tricuspid regurgitation have a higher number and intensity of rejection events. On
the other hand, the progression of cardiac cellular rejection may be accompanied by oedema
and papillary muscle dysfunction, or trigger asymmetrical right ventricular contractility, thus
leading to tricuspid valve regurgitation. Additionally, the high hydrophilic property of the
valve leaflets glycosaminoglycans leads to increased oncotic pressure in the extracellular
matrix during cellular rejection, thus causing oedema and precluding adequate function. In
this regard, there is another outstanding study conducted from the Swedish group of Wartig
et al. [30] that demonstrated in a pretty huge population the impact of the transplantation
techniques on the tricuspid function, as well as its impact on survival. Tricuspid valve regur-
gitation after cardiac transplantation has been argued to be related to the number of biopsies
(although this has been found to be contradictory), to the altered geometry of the right atrial
anastomosis in the BA technique, to the preoperative recipient’s pulmonary vascular resis-
tance, to the ischemic time of the donor’s heart, to the donor-recipient size mismatch, to the
mismatch between the donor’s heart and a large pericardial cavity of the recipient, or to the
presence of TR already in the donor. Wartig et al. revised retrospectively their population of
transplanted patient since 1984, comparing both cohorts of 221 patients receiving BA tech-
nique and 226 receiving BC technique. They observed first that the incidence of early signifi-
cant TR after HTx was more common after the BA technique than after the BC technique.
Furthermore, they demonstrated with a multivariate logistic regression analysis that the BA
technique was the only significant predictor of early moderate to severe TR (odds ratio [OR],
2.70; 95% confidence interval [CI], 1.68–4.32; p 0.001). More interestingly, they found that
moderate and severe TR at discharge was associated with impaired long-term survival. More-
over, it has been previously shown that the degree of TR is related not only to degree of
symptoms and right-sided heart pressures but also to progressive renal dysfunction. When
stratifying for technique, we found more patients with significant TR in the BA group at early
and also 5-year follow-up, compared to the BC group; however, there was no difference at
10 year of follow-up between groups. The explanation might be that patients in the BA group
with significant TR died before 10-year follow-up.
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A good option to palliate the high incidence of tricuspid regurgitation is that patients under-
going HTx should have a prophylactic tricuspid valve annuloplasty [31, 32]. This may be a
good option using the BA technique is used, but when the BC technique is used, prophylactic
tricuspid annuloplasty not only becomes cumbersome intraoperatively, but also unnecessary
because none or mild TR appears to be the case in approximately 80% of patients.
In light of these facts, the superiority of the BC technique demonstrated in many scientific
relevant papers is undebatable. For this reason, some Authors postulated that the BA trans-
plantation technique should no longer be considered the gold standard for transplantation,
and should only be used in selected cases. Thus, today there is no more room for questioning
whether there are advantages of the BC or total techniques over the BA technique, but it is
legitimate to research possible advantages of one technique over the other, providing the
patients with the best treatment.
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